(Q33829100)

29 July 2017

Primary plasma cell leukemia and autologous stem cell transplantation (English)

1 reference

stem cell transplantation

29 July 2017

1 reference

1 reference

6

Dietger Niederwieser

1 reference

29 July 2017

Mary B Drake

1

1 reference

29 July 2017

Simona Iacobelli

2

1 reference

29 July 2017

Anja van Biezen

3

1 reference

29 July 2017

Curly Morris

4

1 reference

29 July 2017

Jane F Apperley

5

1 reference

29 July 2017

Bo Björkstrand

7

1 reference

29 July 2017

Gösta Gahrton

8

1 reference

29 July 2017

European Group for Blood and Marrow Transplantation and the European Leukemia Net

9

1 reference

29 July 2017

language of work or name

1 reference

1 May 2010

1 reference

29 July 2017

1 reference

29 July 2017

95

1 reference

29 July 2017

5

1 reference

29 July 2017

804-809

1 reference

Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukemia

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864387

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864387

A randomized trial of maintenance interferon following high-dose chemotherapy in multiple myeloma: long-term follow-up results

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864387

Consolidation therapy with autologous stem cell transplantation in plasma cell leukemia after VAD, high-dose cyclophosphamide and EDAP courses: a report of three cases and a review of the literature

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864387

Primary plasma cell leukaemia

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864387

Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864387

Plasma cell leukemia. Report on 17 cases

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864387

Plasma cell leukemia: an evaluation of response to therapy

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864387

Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864387

Multiple myeloma: review of 869 cases

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864387

Tumor lysis syndrome after bortezomib therapy for plasma cell leukemia

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864387

Consolidation therapy with autologous blood stem cell transplantation in a patient with primary plasma cell leukaemia

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864387

Primary plasma cell leukemia and multiple myeloma: one or two diseases according to the methodology

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864387

Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864387

p53 and RAS gene mutations in multiple myeloma

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864387

Long-lasting complete remission in plasma cell leukemia after aggressive chemotherapy and CD34-selected autologous peripheral blood progenitor cell transplant: molecular follow-up of minimal residual disease

29 October 2018

1 reference

12 December 2020

The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma

1 reference

12 December 2020

Total therapy with tandem transplants for newly diagnosed multiple myeloma

1 reference

12 December 2020

Long-term survival in primary plasma cell leukemia after therapy with VAD, autologous blood stem cell transplantation and interferon-alpha

1 reference

12 December 2020

Bortezomib is effective in primary plasma cell leukemia

1 reference

12 December 2020

Thalidomide does not modify the prognosis of plasma cell leukemia patients: experience of a single center

1 reference

12 December 2020

Cytogenetic, interphase, and multicolor fluorescence in situ hybridization analyses in primary plasma cell leukemia: a study of 40 patients at diagnosis, on behalf of the Intergroupe Francophone du Myélome and the Groupe Français de Cytogénétique Hé

1 reference

12 December 2020

Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Ma

1 reference

12 December 2020

High-dose intravenous melphalan for plasma-cell leukaemia and myeloma

1 reference

12 December 2020

p53 gene mutations in multiple myeloma are associated with advanced forms of malignancy

1 reference

12 December 2020

Mutational activation of N- and K-ras oncogenes in plasma cell dyscrasias

1 reference

12 December 2020

Long-term disease-free survival after autologous bone marrow transplantation in a primary plasma cell leukaemia: detection of minimal residual disease in the transplant marrow by third-complementarity-determining region-specific probes

1 reference

12 December 2020

Effective autologous peripheral blood stem cell transplantation in plasma cell leukemia followed by T-large granular lymphocyte expansion: a case report

1 reference

12 December 2020

10.3324/HAEMATOL.2009.013334

Identifiers

DOI

1 reference

29 July 2017

1 reference

29 July 2017

1 reference